Your browser doesn't support javascript.
loading
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential.
Orsaria, Paolo; Grasso, Antonella; Carino, Rita; Caredda, Emanuele; Sammarra, Matteo; Altomare, Carlo; Rabitti, Carla; Gullotta, Gabriella; Perrone, Giuseppe; Pantano, Francesco; Buonomo, Oreste Claudio; Altomare, Vittorio.
Afiliación
  • Orsaria P; Department of Breast Surgery, University Campus Bio-Medico, Rome, Italy.
  • Grasso A; Department of Breast Surgery, University Campus Bio-Medico, Rome, Italy.
  • Carino R; Department of Breast Surgery, University Campus Bio-Medico, Rome, Italy.
  • Caredda E; Department of Biomedicine and Prevention, Tor Vergata University Hospital, Rome, Italy.
  • Sammarra M; Department of Radiology, University Campus Bio-Medico, Rome, Italy.
  • Altomare C; Department of Radiology, University Campus Bio-Medico, Rome, Italy.
  • Rabitti C; Department of Human Pathology, University Campus Bio-Medico, Rome, Italy.
  • Gullotta G; Department of Human Pathology, University Campus Bio-Medico, Rome, Italy.
  • Perrone G; Department of Human Pathology, University Campus Bio-Medico, Rome, Italy.
  • Pantano F; Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy.
  • Buonomo OC; Department of Breast Surgery, Tor Vergata University Hospital, Rome, Italy.
  • Altomare V; Department of Breast Surgery, University Campus Bio-Medico, Rome, Italy.
Tumori ; 106(2): 115-125, 2020 Apr.
Article en En | MEDLINE | ID: mdl-31451072
ABSTRACT

BACKGROUND:

Most cases of breast lesions of uncertain malignant potential (B3) undergo surgical intervention. We aimed to analyze the outcome of B3 lesion subtypes in a large series of screen-detected cases.

METHODS:

We screened 2,986 core needle biopsies to classify B3 lesions. Positive predictive values (PPVs) for malignancy were calculated for a comprehensive risk characterization according to clinicopathologic and morphologic variables.

RESULTS:

B3 lesions comprised 35% atypical ductal hyperplasia (PPV = 20%), 16.7% flat epithelial atypia (PPV = 12%), 22.7% lobular neoplasia (PPV = 16.2%), 9% papillary lesion (PPV = 18.5%), 8.6% phyllodes tumor (PPV = 3.8%), and 8% radial scars (PPV = 4.1%) based on histopathologic diagnosis. Upgrade rates were 15.9% for calcifications, 13.7% for mass lesions, and 16.7% for architectural deformities, with 8.3% of malignant lesions classified as ductal carcinoma in situ and 6.7% as invasive cancers (PPV = 15%).

CONCLUSION:

B3 lesions entail a heterogeneous risk of malignancy, and careful radiologic-pathologic correlation is required for optimal treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lesiones Precancerosas / Neoplasias de la Mama / Carcinoma in Situ / Carcinoma Intraductal no Infiltrante Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Tumori Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lesiones Precancerosas / Neoplasias de la Mama / Carcinoma in Situ / Carcinoma Intraductal no Infiltrante Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Tumori Año: 2020 Tipo del documento: Article País de afiliación: Italia
...